KTRA insider transactions
Kintara Therapeutics Inc. (KTRA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for KTRA
- SEC Form 4 filed by Chief Scientific Officer Yamashita Dennis4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- New insider Patel Vijay claimed ownership of 7,999,557 shares (SEC Form 3)3 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Director Ng George K4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- New insider Ng George K claimed no ownership of stock in the company (SEC Form 3)3 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Director List Alan4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- New insider List Alan claimed no ownership of stock in the company (SEC Form 3)3 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Director Manuso James S J4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- New insider Manuso James S J claimed no ownership of stock in the company (SEC Form 3)3 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- New insider Yamashita Dennis claimed no ownership of stock in the company (SEC Form 3)3 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- Chief Executive Officer Bianco James A. was granted 2,323,307 shares (SEC Form 4)4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- New insider Bianco James A. claimed no ownership of stock in the company (SEC Form 3)3 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Dearborn Dan4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- New insider Dearborn Dan claimed no ownership of stock in the company (SEC Form 3)3 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Johnson Laura L.4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Favorito Tamara A4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Hoffman Robert E.4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Brown Dennis M4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Toth Robert Joseph Jr4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Hoffman Robert E.4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: Brown Dennis M transferred by will 363 shares), increasing direct ownership by 7% to 5,302 units4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: Praill Anthony Scott was granted 240,087 shares, increasing direct ownership by 646% to 277,273 units4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: Hoffman Robert E. was granted 400,145 shares, increasing direct ownership by 728% to 455,145 units4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: Brown Dennis M was granted 240,087 shares, increasing direct ownership by 3,521% to 246,905 units4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Johnson Laura L.4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Toth Robert Joseph Jr4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Seymour Tamara A4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: Hoffman Robert E. bought $25,795 worth of shares (55,000 units at $0.47)4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: Praill Anthony Scott bought $19,430 worth of shares (28,700 units at $0.68), increasing direct ownership by 338% to 37,186 units4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: Zarrabian Saiid bought $31,316 worth of shares (50,000 units at $0.63), increasing direct ownership by 909% to 55,500 units4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: Johnson Laura L. bought $2,227 worth of shares (3,000 units at $0.74)4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Hoffman Robert4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Murphy Keith4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Toth Robert Joseph Jr4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Seymour Tamara A4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Hoffman Robert4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by Johnson Laura L.4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4 filed by SEYMOUR TAMARA A4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 3 filed by SEYMOUR TAMARA A3 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: Brown Dennis M converted 750 units into Common Stock, increasing direct ownership by 12% to 6,818 units4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: Praill Anthony Scott converted 938 units into Common Stock, increasing direct ownership by 13% to 8,486 units4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: TOTH ROBERT JOSEPH JR converted 325 units into Common Stock, increasing direct ownership by 26% to 1,566 units4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: Jr Joseph Robert Toth increased direct ownership by 0.65% to 1,238 units4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: M Dennis Brown increased direct ownership by 0.28% to 6,062 units4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)
- SEC Form 4: Scott Anthony Praill increased direct ownership by 0.29% to 7,540 units4 - Kintara Therapeutics, Inc. (0001498382) (Issuer)